BioHarvest Sciences Inc. (BHST)
$1.62-2.41%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $28M
- Beta
- 1.38
- P/E (TTM)
- -2.74
- Short % float
- 0.68%
- Days to cover
- 3.3
- SI change
- +3.9%
- 1W
- +10.20%
- 1M
- -12.43%
- vs SPY 1W
- +9.78%
- vs SPY 1M
- -14.49%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 8
- GROWTH
- 34
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-35.0%
REV YoY-
ROE-58.3%
EPS YoY-
ROA-24.8%
GROSS59
OP-18
NET-31
[VALUATION]
P/E TTM-2.74
P/E FWD-
SECTOR PE17.69
INDUSTRY PE-
P/B1.70
P/FCF-
EV/EBITDA-3.70
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E88.79
ALTMAN Z-
CURR RATIO2.24
ND/EBITDA-
BETA1.38
Company news
FAQ
- What is LOPJLB’s current signal on BHST?
- LOPJLB’s latest quantitative signal on BioHarvest Sciences Inc. (BHST) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BHST in?
- BioHarvest Sciences Inc. (BHST) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does BioHarvest Sciences Inc. (BHST) do?
- BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as o…